What should I Know Regarding Pregnancy, Nursing and Administering Erlotinib 150 Mg Tablet Antineoplastic - Protein-Tyrosine Kinase Inhibitors to Children or the Elderly?
If you are PREGNANT
- Not Recommended: MFR RECOMMENDS CONTRACEPTION DURING THERAPY AND 2 WKS AFTER THERAPY IS COMPLETED
If you are NURSING
- Absolute Contraindication: INSUFF DATA AVAIL; POT FOR SERIOUS TOXICITY
If you are an adult over 60
- management or monitoring precaution: General-Dehydration increases risk of renal failure. Monitor electrolytes and renal function.
Giving Erlotinib 150 Mg Tablet Antineoplastic - Protein-Tyrosine Kinase Inhibitors to a child under 12
- Severe Precaution: No established efficacy in pediatrics in trials for recurrent or refractory ependymoma.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.